SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Debiopharm and Aurigene Discovery Technologies Limited Sign Agreement for the Development and Commercialisation of Debio 1142, A Novel Inhibitor of an Undisclosed Oncology Pathway